Nilsine Partners LLC raised its stake in AdvanSix (NYSE:ASIX – Free Report) by 2.8% in the 1st quarter, HoldingsChannel reports. The fund owned 21,891 shares of the company’s stock after buying an additional 603 shares during the quarter. Nilsine Partners LLC’s holdings in AdvanSix were worth $496,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Ameriprise Financial Inc. increased its position in AdvanSix by 0.3% in the 4th quarter. Ameriprise Financial Inc. now owns 135,127 shares of the company’s stock valued at $3,850,000 after acquiring an additional 450 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in AdvanSix by 3.6% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,543 shares of the company’s stock valued at $414,000 after acquiring an additional 508 shares in the last quarter. Two Sigma Advisers LP increased its position in AdvanSix by 2.8% in the 4th quarter. Two Sigma Advisers LP now owns 29,300 shares of the company’s stock valued at $835,000 after acquiring an additional 800 shares in the last quarter. GAMMA Investing LLC increased its position in AdvanSix by 149.5% in the 1st quarter. GAMMA Investing LLC now owns 1,966 shares of the company’s stock valued at $45,000 after acquiring an additional 1,178 shares in the last quarter. Finally, Rhumbline Advisers increased its position in AdvanSix by 1.4% in the 4th quarter. Rhumbline Advisers now owns 84,984 shares of the company’s stock valued at $2,421,000 after acquiring an additional 1,198 shares in the last quarter. Institutional investors and hedge funds own 86.39% of the company’s stock.
AdvanSix Stock Down 1.2%
AdvanSix stock opened at $23.44 on Friday. The company’s 50 day simple moving average is $22.86 and its 200 day simple moving average is $25.82. AdvanSix has a fifty-two week low of $18.44 and a fifty-two week high of $33.00. The firm has a market capitalization of $628.45 million, a price-to-earnings ratio of 7.51 and a beta of 1.62. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.19 and a quick ratio of 0.56.
AdvanSix Dividend Announcement
Insiders Place Their Bets
In other AdvanSix news, SVP Achilles B. Kintiroglou sold 4,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 1st. The shares were sold at an average price of $22.24, for a total transaction of $88,960.00. Following the sale, the senior vice president now directly owns 36,363 shares in the company, valued at approximately $808,713.12. This trade represents a 9.91% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 5.60% of the company’s stock.
Wall Street Analyst Weigh In
Several equities research analysts have weighed in on the stock. UBS Group set a $35.00 price objective on shares of AdvanSix in a research report on Tuesday, March 18th. Wall Street Zen upgraded shares of AdvanSix from a “buy” rating to a “strong-buy” rating in a research report on Saturday, May 31st. Finally, Piper Sandler set a $32.00 target price on shares of AdvanSix in a research note on Monday, May 19th.
Get Our Latest Research Report on AdvanSix
About AdvanSix
AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.
Featured Stories
- Five stocks we like better than AdvanSix
- Overbought Stocks Explained: Should You Trade Them?
- GE Aerospace Turns Engines Into Long-Term Profits
- How to Effectively Use the MarketBeat Ratings Screener
- Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes
- Trading Halts Explained
- Marvell’s New AI Chip Deals Capture Wall Street’s Attention
Want to see what other hedge funds are holding ASIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AdvanSix (NYSE:ASIX – Free Report).
Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.